These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18221037)

  • 21. Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.
    Wargo JA; Reuben A; Cooper ZA; Oh KS; Sullivan RJ
    Semin Oncol; 2015 Aug; 42(4):601-16. PubMed ID: 26320064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The interplay of immunotherapy and chemotherapy: harnessing potential synergies.
    Emens LA; Middleton G
    Cancer Immunol Res; 2015 May; 3(5):436-43. PubMed ID: 25941355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects.
    Lu Y; Low PS
    J Control Release; 2003 Aug; 91(1-2):17-29. PubMed ID: 12932634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation therapy and immunotherapy: implications for a combined cancer treatment.
    Levy A; Chargari C; Cheminant M; Simon N; Bourgier C; Deutsch E
    Crit Rev Oncol Hematol; 2013 Mar; 85(3):278-87. PubMed ID: 23036459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nanoparticulate immunotherapy for cancer.
    Kapadia CH; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2015 Dec; 219():167-180. PubMed ID: 26432555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combining radiation, immunotherapy, and antiangiogenesis agents in the management of cancer: the Three Musketeers or just another quixotic combination?
    Kamrava M; Bernstein MB; Camphausen K; Hodge JW
    Mol Biosyst; 2009 Nov; 5(11):1262-70. PubMed ID: 19823740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
    Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
    Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1977 Henry H. Janeway lecture: fundamental mechanisms in combined modality therapy of cancer.
    Kaplan HS
    AJR Am J Roentgenol; 1977 Sep; 129(3):383-93. PubMed ID: 409189
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunotherapy in the treatment of cancers].
    Tartour E; Dorval T; Lee RS; Fridman WH
    Presse Med; 1996 Nov; 25(35):1717-22. PubMed ID: 8977585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy.
    Yan Y; Kumar AB; Finnes H; Markovic SN; Park S; Dronca RS; Dong H
    Front Immunol; 2018; 9():1739. PubMed ID: 30100909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of radio-sensitization patents in China from 2006 to 2015.
    He G; Di X; Sun X; Yan J; Zhang S
    Expert Opin Ther Pat; 2017 Oct; 27(10):1159-1172. PubMed ID: 28621575
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment.
    Graham K; Unger E
    Int J Nanomedicine; 2018; 13():6049-6058. PubMed ID: 30323592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging biology of modern radiation oncology.
    Goffman TE; Raubitschek A; Mitchell JB; Glatstein E
    Cancer Res; 1990 Dec; 50(24):7735-44. PubMed ID: 2253216
    [No Abstract]   [Full Text] [Related]  

  • 36. Gene therapy strategies to improve the effectiveness of cancer radiotherapy.
    Freytag SO; Kim JH; Brown SL; Barton K; Lu M; Chung M
    Expert Opin Biol Ther; 2004 Nov; 4(11):1757-70. PubMed ID: 15500404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Concomitant chemo-radiation treatment of malignant tumors: biological bases].
    Inciūra A; Juozaityte E
    Medicina (Kaunas); 2002; 38(10):1042-9; quiz 1051. PubMed ID: 12532716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination of radiotherapy and immune treatment: First clinical data.
    De Ruysscher D
    Cancer Radiother; 2018 Oct; 22(6-7):564-566. PubMed ID: 30170788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From a Patient Advocate's Perspective: Does Cancer Immunotherapy Represent a Paradigm Shift?
    Madden DL
    Curr Oncol Rep; 2018 Feb; 20(1):8. PubMed ID: 29411148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining gene therapy and radiation against cancer.
    Gridley DS; Slater JM
    Curr Gene Ther; 2004 Sep; 4(3):231-48. PubMed ID: 15384938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.